Two new drug treatments for variant CJD, the human version of mad cow
disease, will be tested in Britain. A team led by Carsten Korth and Stanley
Prusiner at the University of California, San Francisco, has found that both
drugs—already used to treat malaria and schizophrenia—halt the
progress of the disease in cell culture. A 20-year-old British woman with vCJD
is reported to have shown marked improvement following treatment, but a second
patient is said to be no better. The Department of 91É«ÇéƬ says the drugs could
be tested on seven British vCJD patients as soon as trials…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
91É«ÇéƬ
I’m the first person whose life was saved by CRISPR base editing
News
Technology
US government wants to have a useful quantum computer by 2028
News
Life
Childbirth for many primate species is even harder than for humans
News
Humans
Humans sleep the least of all apes – is it the secret to our success?
Features
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Our verdict on The Selfish Gene: An unpopular piece of popular science
3
We’ve uncovered a master gene that switches on human development
4
US government wants to have a useful quantum computer by 2028
5
The best sci-fi novel in 2026 so far – plus 6 other great reads
6
Remote-controlled cockroach swarm can now breathe underwater
7
Humans sleep the least of all apes – is it the secret to our success?
8
Ancient human DNA found on cave art for the first time
9
I have a 100 per cent chance of getting cancer due to a rare gene
10
If you aren't terrified by this heatwave, you should be
